Engineering of membrane protein chemosensors for therapeutic research
Award amount
$1,213,215Program and phase
SBIR · Phase IIAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INTEGRAL MOLECULAR INC
- Proposal award date
- 2013-12-01
- Contract end date
- 2018-05-31
- UEI
- DY9KSWE8EJB8
- Solicitation number
- PA11-134
- Topic code
- NIDCD
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- ANTIBODY REAGENTS FOR IMMUNOLOGIC ANALYSIS OF UNDER-REPRESENTED MAMMALIAN MODELS
- High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA
- Specificity Screening Drug Development Tool for Biotherapeutic Safety
- Development of Safe and Rapid Reporter Viruses for Studying Pathogenic and Pandemic Viruses
- Reagents for Immunologic Analysis of Under-represented Mammalian Models
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Cell type-specific gene therapy approach for TOMT-linked congenital hearing loss
- Real time speech enhancement/noise reduction for the hearing impaired
- Development of a Navigation-Based Insertion Tool for Trajectory Optimization during Cochlear Implantation
- Phonocath - An endovascular medical device to objectively evaluate Pulsatile Tinnitus
- Smartphone based custom-fit and low-cost hearing aids manufacturing system
Research funding history
48 SBIR/STTR records share this UEI (2002–2025). Reported award amounts total $32,839,788. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services